Literature DB >> 21806764

Prevalence, determinants, and clinical significance of cardiac troponin-I elevation in individuals admitted for a hypertensive emergency.

Luis Afonso1, Himabindu Bandaru, Ankit Rathod, Apurva Badheka, Mohammad Ali Kizilbash, Hammam Zmily, Gordon Jacobsen, Joseph Chattahi, Tamam Mohamad, Jayanth Koneru, John Flack, W Douglas Weaver.   

Abstract

Hypertensive emergencies (HEs) are frequently accompanied with the release of cardiac troponin I (cTnI); however, determinants and clinical significance of cTnI elevation are largely unknown. A retrospective analysis was performed on patients (n = 567) with a diagnosis of HE admitted to two tertiary care centers that primarily serve an inner-city population. Data on demographics, clinical variables, and cTnI were collected through chart review. Using regression analyses, predictors of cTnI elevation were studied and the impact of cTnI on all-cause mortality (data obtained through the Social Security Death Index) was determined. cTnI elevation was observed in 186 (32.3%) admissions with a mean peak cTnI level of 4.06 ± 14.6 ng/mL. Predictors of cTnI were age, history of hypercholesterolemia, blood urea nitrogen level, pulmonary edema, and requirement for mechanical ventilation. During a mean follow-up period of 3.1 years, there were 211 deaths (37%). Neither the presence nor the extent of cTnI elevation was associated with mortality, while age, history of coronary artery disease, and blood urea nitrogen level were predictive of mortality. cTnI elevation commonly occurs in the setting of HEs. Despite a high incidence of adverse clinical outcomes, cTnI elevation was not an independent predictor of mortality in this population.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806764      PMCID: PMC8108865          DOI: 10.1111/j.1751-7176.2011.00476.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  29 in total

Review 1.  Hypertensive pulmonary oedema is due to diastolic dysfunction.

Authors:  W C Little
Journal:  Eur Heart J       Date:  2001-11       Impact factor: 29.983

2.  Troponin I as a specific marker of myocardial injury: from theory to clinical practice in the diagnosis of acute coronary syndrome.

Authors:  Chiara Bucciarelli-Ducci; Cristina Rasile; Paola Proietti; Massimo Mancone; Cristina Volponi; Annarita Vestri; Francesco Fedele
Journal:  Coron Artery Dis       Date:  2004-12       Impact factor: 1.439

3.  Stretch-induced programmed myocyte cell death.

Authors:  W Cheng; B Li; J Kajstura; P Li; M S Wolin; E H Sonnenblick; T H Hintze; G Olivetti; P Anversa
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 4.  Pathophysiology, clinical aspects, and treatment of hypertensive crises.

Authors:  M C Houston
Journal:  Prog Cardiovasc Dis       Date:  1989 Sep-Oct       Impact factor: 8.194

5.  Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease.

Authors:  Christophe Baillard; Mohamed Boussarsar; Jean-Philippe Fosse; Emmanuelle Girou; Philippe Le Toumelin; Christophe Cracco; Samir Jaber; Yves Cohen; Laurent Brochard
Journal:  Intensive Care Med       Date:  2003-02-13       Impact factor: 17.440

Review 6.  Troponin I and T levels in renal failure patients without acute coronary syndrome: a systematic review of the literature.

Authors:  Dale M Needham; Kathryn A Shufelt; George Tomlinson; James W Scholey; Gary E Newton
Journal:  Can J Cardiol       Date:  2004-10       Impact factor: 5.223

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

8.  Complications and survival of 315 patients with malignant-phase hypertension.

Authors:  G Y Lip; M Beevers; D G Beevers
Journal:  J Hypertens       Date:  1995-08       Impact factor: 4.844

9.  Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.

Authors:  Leonardo A Sechi; Marileda Novello; GianLuca Colussi; Alessandro Di Fabio; Alessandra Chiuch; Elisa Nadalini; Alessia Casanova-Borca; Alessandro Uzzau; Cristiana Catena
Journal:  Am J Hypertens       Date:  2008-10-23       Impact factor: 2.689

10.  Cardiac function and brain-type natriuretic peptide in first-time flash pulmonary edema.

Authors:  Jacob P Dal-Bianco; Allan S Jaffe; Malcolm R Bell; Jae K Oh
Journal:  Mayo Clin Proc       Date:  2008-03       Impact factor: 7.616

View more
  12 in total

1.  Disease distribution and outcome in troponin-positive patients with or without revascularization in a chest pain unit: results of the German CPU-Registry.

Authors:  Alexander Illmann; Thomas Riemer; Raimund Erbel; Evangelos Giannitsis; Christian Hamm; Michael Haude; Gerd Heusch; Lars S Maier; Thomas Münzel; Claus Schmitt; Burghard Schumacher; Jochen Senges; Thomas Voigtländer; Harald Mudra
Journal:  Clin Res Cardiol       Date:  2014-01       Impact factor: 5.460

Review 2.  Novel Biomarkers to Detect Target Organ Damage in Acute Hypertension.

Authors:  Stephen Boone; Dick Kuo
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

Review 3.  Therapeutic Approach to Hypertension Urgencies and Emergencies in the Emergency Room.

Authors:  Alessandro Maloberti; Giulio Cassano; Nicolò Capsoni; Silvia Gheda; Gloria Magni; Giulia Maria Azin; Massimo Zacchino; Adriano Rossi; Carlo Campanella; Andrea Luigi Roberto Beretta; Andrea Bellone; Cristina Giannattasio
Journal:  High Blood Press Cardiovasc Prev       Date:  2018-05-18

4.  Age-related adaptation of bone-PDL-tooth complex: Rattus-Norvegicus as a model system.

Authors:  Narita L Leong; Jonathan M Hurng; Sabra I Djomehri; Stuart A Gansky; Mark I Ryder; Sunita P Ho
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

5.  The regulation of troponins I, C and ANP by GATA4 and Nkx2-5 in heart of hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus.

Authors:  Bryan E Luu; Shannon N Tessier; Dianna L Duford; Kenneth B Storey
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

6.  Hospital and out-of-hospital mortality in 670 hypertensive emergencies and urgencies.

Authors:  Haythem Guiga; Clémentine Decroux; Pierre Michelet; Anderson Loundou; Dimitri Cornand; François Silhol; Bernard Vaisse; Gabrielle Sarlon-Bartoli
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-03       Impact factor: 3.738

7.  An inhibitor of the δPKC interaction with the d subunit of F1Fo ATP synthase reduces cardiac troponin I release from ischemic rat hearts: utility of a novel ammonium sulfate precipitation technique.

Authors:  Mourad Ogbi; Ijeoma Obi; John A Johnson
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

8.  Complexation and sequestration of BMP-2 from an ECM mimetic hyaluronan gel for improved bone formation.

Authors:  Marta Kisiel; Agnieszka S Klar; Manuela Ventura; Jos Buijs; Marc-Krystelle Mafina; Simon M Cool; Jöns Hilborn
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

9.  Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.

Authors:  E S Bijsmans; R E Jepson; C Wheeler; H M Syme; J Elliott
Journal:  J Vet Intern Med       Date:  2017-04-07       Impact factor: 3.333

10.  Determinants and prognosis of high-sensitivity cardiac troponin T peak plasma concentration in patients hospitalized for non-cardiogenic shock.

Authors:  Marie Caujolle; Jerome Allyn; Caroline Brulliard; Dorothée Valance; David Vandroux; Olivier Martinet; Nicolas Allou
Journal:  SAGE Open Med       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.